Published March 14, 2020
| Version 3.1
Patent
Open
An Antiviral Formulation consisting of Viral DNA Gyrase & RNA Polymerase Suppressive Protopanaxatriol Analouges for the Treatment of Coronaviral Infections
Authors/Creators
Description
A Formulation with Protopanaxatriol Class Glucopyranoside Analouges that exerts Simultaneous RNA Dependent RNA Polymerase and Viral DNA Gyrase Suppressive Properties for the Treatment of Coronaviral & Adenoviral Infections
Files
201304493.pdf
Files
(459.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:ba266e8c3fc095981c100f014488bfa6
|
26.7 kB | Download |
|
md5:b83d625916fdce97326bad5b0b4d8e1f
|
139.6 kB | Preview Download |
|
md5:c90e9f50f27cb9658f3dbea12f402725
|
130.7 kB | Preview Download |
|
md5:f35131a706d25d9792dc9e6a5d56c080
|
139.1 kB | Preview Download |
|
md5:cf37404c5cddef52f20752d1ba4cb0a2
|
22.9 kB | Download |